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Introduction
The sarcoplasmic reticulum (SR) of the skeletal muscle and
the transverse tubular membranes provide a conducive
environment enriched with key proteins that have been shown
to play an essential role in excitation-contraction (E-C)
coupling (Endo, 1977; Fleischer and Inui, 1989). E-C coupling
occurs in specialized junctions called triads, which are an
intracellular synapse formed by the membrane system of the
transverse tubule and the terminal cisternae of the SR. The two
main Ca2+ channels involved in E-C coupling are the
dihydropyridine receptor, Cav1, which lies on the transverse
tubules where it acts as a voltage sensor for E-C coupling, and
the ryanodine receptor (RyR), present on the junctional face
membrane of the SR, which is the Ca2+ release channel
(Franzini-Armstrong and Jorgensen, 1994; Meissner, 1994; Ma
and Pan, 2003; Sutko and Airey, 1996; Franzini-Armstrong,
1980; Lamb and Stephenson, 1990; Rios and Pizzarro, 1991).
Cav1 is a hetero-oligomeric complex made up of at least four
subunits: 1, , 2 and  (Leung et al., 1987; Lacerda et al.,
1991; Birnbaumer et al., 1998; Catterall, 1995; Snutch and
Reiner, 1992). The pore-forming Cav1.1 is an integral
membrane protein and is indispensable for E-C coupling,
whereas the cytosolic 1a and 2 subunits have regulatory
functions; the role of the  subunit has yet to be clearly defined
(Catterall, 1995; Snutch and Reiner, 1992, Tsien et al., 1991).
The 1a subunit associates tightly with the Cav1.1 by binding
to a region on the I-II loop termed -interacting domain (AID)
(Pragnell et al., 1994). The 1a subunit is important for plasma
membrane expression of the Cav1.1, whereas a sequence
located in the C-terminal domain of the Cav1.1 seems to be
involved in triad targeting (Chien et al., 1995; Flucher et al.,
2000; Flucher et al., 2002), although other domains and/or
polypeptides might be involved in proper targeting.
In skeletal muscle, Cav1.1 responds to transverse tubule
depolarisation by sensing the voltage change and it induces
Ca2+ release from the SR through a direct interaction with the
RyR. Besides the RyR, however, the junctional face membrane
contains numerous other proteins that, because of their
anatomical location, are deemed to be involved in E-C coupling
(Zhang et al., 1997; Costello et al., 1986; Zorzato et al., 2000).
In the past few years a number of investigators have begun to
define the major and minor structural components of the
junctional face membrane (Ito et al., 2001; Takeshima et al.,
2000). In previous studies (Zorzato et al., 2000; Anderson et
al., 2003), we identified and characterized – at the biochemical
and molecular level – JP-45, an integral membrane protein
JP-45, an integral protein of the junctional face membrane
of the skeletal muscle sarcoplasmic reticulum (SR),
colocalizes with its Ca2+-release channel (the ryanodine
receptor), and interacts with calsequestrin and the skeletal-
muscle dihydropyridine receptor Cav1. We have identified
the domains of JP-45 and the Cav1.1 involved in this
interaction, and investigated the functional effect of JP-45.
The cytoplasmic domain of JP-45, comprising residues 1-
80, interacts with Cav1.1. JP-45 interacts with two distinct
and functionally relevant domains of Cav1.1, the I-II loop
and the C-terminal region. Interaction between JP-45 and
the I-II loop occurs through the -interacting domain in the
I-II loop. 1a, a Cav1 subunit, also interacts with the
cytosolic domain of JP-45, and its presence drastically
reduces the interaction between JP-45 and the I-II loop.
The functional effect of JP-45 on Cav1.1 activity was
assessed by investigating charge movement in
differentiated C2C12 myotubes after overexpression or
depletion of JP-45. Overexpression of JP-45 decreased peak
charge-movement and shifted VQ1/2 to a more negative
potential (–10 mV). JP-45 depletion decreased both the
content of Cav1.1 and peak charge-movements. Our data
demonstrate that JP-45 is an important protein for
functional expression of voltage-dependent Ca2+ channels.
Key words: Voltage-dependent Ca2+ channel, JP-45, Sarcoplasmic
reticulum, Excitation-contraction coupling
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constituent of the SR junctional face membrane in skeletal
muscle. We also showed that JP-45 colocalizes with the RyR
Ca2+-release channel and interacts with Cav1.1 and the luminal
Ca2+-binding protein calsequestrin (Anderson et al., 2003). To
gather insight into the functional role of JP-45, we defined the
domains involved in the interaction between JP-45 and Cav1.1.
Our results demonstrate that the cytoplasmic domain of JP-45
interacts directly with the I-II loop, the C-terminal domain of
Cav1.1 subunit and also with the 1a subunit of Cav1. In
addition, we show that the interaction between JP-45 and the
I-II loop occurs through the AID domain, and can be displaced
by 1a. Experimental evidence has demonstrated that the 1a
subunit interacts with the Cav1.1 subunit via AID (Pragnell et
al., 1994; Chen et al., 2004) and that this protein-protein
interaction is involved in the insertion of the voltage sensor to
its proper membrane compartment (Flucher et al., 2002). To
confirm the functional role of JP-45 in vivo, we overexpressed
and silenced endogenous JP-45 in C2C12 cells and studied
their electrophysiological properties. Based on the results of
the present report, JP-45 is involved in the regulation of the
functional expression of Cav1.1 into the transverse tubular
membrane compartment.
Results and Discussion
Identification of domains enabling the interaction of JP-
45 and Cav1.1
In a previous report, we demonstrated that JP-45 interacts with
native Cav1.1 (Anderson et al., 2003). Here, we describe a
series of experiments to identify the domains participating in
this interaction. We prepared recombinant GST-fusion proteins
covering different coding regions of JP-45 (excluding the
transmembrane domain) (see Fig. 1). These proteins were then
bound to glutathione-Sepharose beads and incubated with
solubilized light microsomal vesicles. Fig. 2A shows that the
cytoplasmic N-domain of JP-45, more specifically the region
between residues 1-80 (domain 2) interacts with native Cav1.1.
No interaction was observed between any other JP-45 domains
and Cav1.1. The physiological relevance of the interaction of
fusion proteins was verified by studying the effect of the GST-
JP-45 domain 2 on co-immunoprecipitation of Cav1.1 with a
monoclonal anti-JP-45 antibody (Ab). The interaction between
native JP-45 and Cav1.1 was competed-out by the presence of
soluble GST-JP-45 domain 2 in the co-immunoprecipitation
reaction (Fig. 2B).
Extensive structure-to-function relationship studies on Cav1
have helped to define functionally relevant domain boundaries
not only among the subunits making up the supramolecular
complex, but also within the primary structure of each subunit
(Nakai et al., 1998; Grabner et al., 1999; Kugler et al., 2004; Van
Petegem et al., 2004). We reasoned that the physiological
relevance of the interaction between Cav1.1 and JP-45 could
be better understood if we first identified JP-45-binding sites
within the Cav1.1. GST-JP-45 domain-2 fusion protein was
immobilized on GST-Sepharose and incubated with different
His-tagged fusion proteins, covering the cytoplasmic domains of
the Cav1.1 subunit (Tanabe et al., 1987). Whereas some of the
His-tagged fusion proteins display the expected molecular mass,
they had in other cases a molecular mass lower than the expected
value due to the instability of purified fusion proteins (Fig. 3A,
lanes 3 and 7). The protein-protein-interaction experiments
depicted in Fig. 3B demonstrate that the I-II loop and the C-
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terminal domain of the Cav1.1 as well as the 1a subunit interact
with JP-45, whereas fusion proteins corresponding to the N-
terminus – the II-III and III-IV loops of the Cav1.1 subunit – do
not interact with GST-JP-45 domain-2 fusion protein. To validate
these results, we performed pull-down experiments using GST-
JP-45 domain 2 as bait and solubilized light microsomal vesicles
as ligand, in the presence or absence of increasing concentrations
of either I-II loop or recombinant C-terminal-distal His-tag
fusion proteins. Inhibition of Cav1.1-GST-JP-45 interaction was
achieved at 3.6 and 1.25 M of I-II loop and C-terminal-distal
His-tag fusion proteins, respectively. To further confirm the
specificity of the pull-down assay, we also investigated these
interactions under native conditions, i.e. by performing co-
immunoprecipitation of native JP-45 with Cav1.1 using the
monoclonal anti-JP-45 Ab, in the presence or absence of
competing I-II loop or recombinant C-terminal-distal His-tag
fusion proteins. As shown in Fig. 3D, the presence of the
competing recombinant fusion proteins substantially diminished
the interaction between JP-45 and the Cav1.1 domains. Pull-
down and co-immunoprecipitation assays demonstrated that
competition with one of the Cav1.1 interacting domains (I-II loop
or C-terminal-distal His-tag fusion proteins) was sufficient to
partially inhibit the interaction. At a first glance it seems unclear
how preventing the Cav1.1–JP-45 interaction through a single
domain reduces total binding to the Cav1.1 to almost zero. A
plausible explanation of the experiments is described in Fig. 3C
and D; addition of excess I-II loop or C-terminal-distal loop
occupies the interacting domain of the N-terminal domain of JP-
45. Binding of the 50 aa-long JP-45 binding sites by an excess
of the 14 kDa or 30 kDa Cav1.1 loops (I-II and C-terminal,
respectively) most probably creates a steric hindrance, whereby
the interaction of alternative domains within the native
solubilized Cav1.1 is either abolished or substantially weakened.
Immunoprecipitation experiments revealed that JP-45
Fig. 1. Domains of JP-45 used to identify the Cav1.1 binding sites.
(A) Schematic representation. (B) 10% SDS-PAGE and Coomassie
Brilliant Blue staining of the GST-JP-45 fusion proteins purified by
glutathione-Sepharose. The numbers above each lane indicate the aa
residues that were fused in frame in the pGex plasmid to yield the
GST-JP-45 fusion protein.
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2147JP-45 interacts with the skeletal muscle DHP-receptor Cav1.1
Fig. 2. Identification of the JP-45 domain interacting with Cav1.1. (A) GST-JP-45 fusion proteins encompassing different domains of JP-45
were bound to glutathione-Sepharose beads and incubated with solubilized rabbit skeletal-muscle microsomal vescicles as described in
Materials and Methods. Proteins present in the void (V), last wash (LW) and bound to the beads (B) were separated on a 10% SDS-PAGE,
transferred onto nitrocellulose and the presence of the bound Cav1.1 was revealed by western blotting with commercial anti-Cav1.1 Abs. (B)
Co-immunoprecipitation experiment with monoclonal anti-JP-45 Ab to pull-down Cav1.1. Experiments were performed as described in the
Materials and Methods. Where indicated, recombinant GST-JP-45 domain-2 fusion protein was used to compete-out the interaction between
endogenous proteins present in the microsomes forming a supramolecular complex.
Fig. 3. Identification of Cav1.1 domains interacting with JP-45. Cav1.1 domains I-II, C-terminal-distal and C-terminal-proximal His-tag fusion
proteins, and subunit 1a interact with the cytosolic domain of JP-45. (A) Immunoblot of purified His-tagged fusion proteins encompassing the
different Cav1.1 domains (10% tricine SDS-PAGE) and 1a (10% SDS-PAGE). Immunostaining was carried out using commercial anti-poly-
His Abs followed by HR-conjugated anti-mouse IgG; bands were visualized by chemiluminescence. (B) Pull-down of His-tagged fusion
proteins with domain 2 of JP-45 (aa residues 1-80). GST-JP-45 domain-2 fusion protein was bound to glutathione-Sepharose beads and
incubated with the His-tagged recombinant Cav1.1 proteins. Proteins present in the void (V) or bound to the beads (B) were separated on a 10%
tricine SDS-PAGE or 10% SDS-PAGE (for the 1a subunit), blotted onto nitrocellulose and visualized in western blots by using anti-poly-His
Ab as described above. (C) GST-JP-45 domain-2 fusion protein was bound to glutathione-Sepharose beads and incubated with solubilized light
SR vescicles isolated from rabbit skeletal muscle in the presence of the indicated concentration of competing His-tagged I-II loop or C-
terminal-distal His-tag fusion proteins. (D) Monoclonal anti-JP-45 Abs were used to co-immunoprecipitate the complex from solubilized light
microsomal vescicles isolated from rabbit skeletal muscle in the presence of the indicated concentration of competing His-tagged I-II loop or C-
terminal-distal fusion proteins. Proteins bound to the beads were separated in a 10% SDS-PAGE, transferred onto nitrocellulose and probed
with anti-Cav1.1 Abs.
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interacts with the I-II loop of subunit Cav1.1 and with purified
recombinant 1a subunit (Fig. 3B). The 1a has been shown
to interact strongly with the I-II loop of the 1.1 subunit and
to affect its functional expression (Flucher et al., 2000; Chien
et al., 1995). In the next set of experiments, we therefore
characterized in greater detail the latter protein-protein
interaction.
Effect of the 1a subunit on the interaction of JP-45 and
Cav1.1 
We investigated the role of the 1a subunit on the interaction
between JP-45 and Cav1.1 by pull-down and co-
immunoprecipitation assays (Fig. 4). JP-45 domain-2 fusion
protein was immobilized on GST-Sepharose and incubated with
the His-tagged Cav1.1 subunit I-II loop fusion protein in the
presence or absence of increasing concentrations of  1a fusion
protein. As seen in Fig. 4A the presence of 1a interferes with
the interaction between the I-II loop and JP-45. Pull-down assays
were also performed by using the solubilized light microsomal
vesicles as ligand. In the latter case, the association between the
GST-JP-45 domain-2 fusion protein and the native Cav1.1
subunit was remarkably weaker in the presence of excess 1a-
His-tagged fusion protein (Fig. 4B). The interference of the
interaction between JP-45 and the Cav1.1 subunit by excess 1a,
was also confirmed by performing co-immunoprecipitation
experiments with anti-JP-45 Abs to pull-down the native
solubilized complex (Fig. 4C). These results suggest that the
presence of excess 1a disrupts the complex between Cav1.1 and
JP-45. We cannot discriminate whether JP-45 interacts with the
Cav1.1 or 1a, subunit, or whether JP-45 interacts with both
subunits, thereby forming an oligomeric complex.
The Cav1 1a subunit has been shown to bind strongly to
the intracellular loop between transmembrane domain I and II
of the Cav1.1, a region composed of 18 aa displaying the motif
QQ-E-L-GY-WI-E, conserved in different isoforms (Pragnell
et al., 1994). This binding domain is also referred to as -
interacting domain (AID). It is thought that the interaction
between AID and the 1a subunit is important to determine the
stability of this Ca2+ channel on the plasma membrane
(Birnbaumer et al., 1998; Flucher et al., 2000; Flucher et al.,
2002; Chien et al., 1995; Ahern et al., 2003; Bichet et al.,
2000). In addition, the interaction between AID and 1a is
regarded to the major structural determinant required for the
surface expression of Cav1.1 (Chien et al., 1995; Beurg et al.,
1999; Gregg et al., 1996; Jones et al., 1998). Coexpression of
Cav1.1 and 1a subunits has been shown to increase the density
and kinetics of L-type Ca2+ currents, and experimental
evidence suggest that the 1a subunit facilitates gating of
Cav1.1 by increasing the coupling between charge movement
and pore opening (Sheridan et al., 2003; Sheridan et al., 2004).
These effects of the 1a subunit are due to its interaction with
the I-II loop, a domain that also interacts with JP-45. In the
next set of experiments we addressed the question of whether
the 1a subunit and JP-45 share the AID domain as binding
site on the I-II loop. To address this issue, we performed pull-
down assays with (1) GST-I-II loop fusion protein, (2) with a
GST-fusion protein containing AID flanked by 21 and 11
residues at the N-terminal and C-terminal end, respectively,
and (3) with a synthetic biotinylated-AID peptide. For the first
two assays, the GST-fusion proteins were used as bait and the
His-tagged JP-45 domain-2 fusion protein as ligand. The
apparent molecular mass of His-tagged JP-45 domain 2 is
Journal of Cell Science 119 (10)
Fig. 4. Effect of the 1a subunit on the
interaction between JP-45 and Cav1.1.
(A) Interaction between GST-JP-45 and His I-
II loop in the presence of competing purified
1a subunit. For the fusion-protein–protein
interaction, 0.57 M of GST-JP-45 domain 2
and 1.4 M I-II loop fusion protein were
incubated in the presence of the indicated
concentration of His-tagged 1a subunit. His-
tagged I-II loop fusion proteins bound to
glutathione-Sepharose beads coated with GST-
JP-45 domain-2 fusion protein were separated
on a 10% tricine SDS-PAGE and probed with
anti-poly-His Ab as described in the legend to
Fig. 3. (B) Solubilized rabbit skeletal-muscle
light SR vesicles were incubated with
glutathione-Sepharose beads coated with GST-
JP-45 domain-2 fusion protein in the absence
or presence of purified 1a subunit. Proteins
present in the void (V) and bound to the beads
(B), were separated on a 10% SDS-PAGE,
blotted onto nitrocellulose and probed with
anti-1.1 subunit Ab. (C) Solubilized rabbit
skeletal-muscle light SR vesicles were
incubated with anti-JP-45 Ab followed by
incubation with Sepharose-protein G beads in
the absence or presence of competing purified
1a subunit. Proteins present in the void (V)
and bound to the beads (B), were separated on
a 10% SDS-PAGE, blotted onto nitrocellulose
and probed with anti-Cav1.1 Ab.
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2149JP-45 interacts with the skeletal muscle DHP-receptor Cav1.1
larger than the theoretical predicted values (approx. 31 kDa vs
14 kDa, respectively). We are confident that the apparent larger
molecular mass of the His-tagged JP-45 domain-2 fusion
protein is due its dimerization, because its treatment with
DEPC (which destroys the His tag) abolished the binding of
the anti-His tag Ab (Fig. 5 panel C). Western blot analysis (Fig.
5A,B) demonstrates that JP-45 domain 2 interacts directly with
the AID sequence within the I-II loop. The in vitro interaction
of the sequence containing AID and JP-45 occurs at
micromolar concentrations of His-tagged JP-45 domain-2
fusion protein. Because of such a high concentration it is
probably that, under physiological conditions, the interaction
between the 1a subunit and AID prevails over that of JP-45
and AID. Nevertheless, on the basis of the highly organized
molecular assembly of the triad membranes, we cannot exclude
the possibility that the local concentration of JP-45 in the
triadic gap is sufficient to interfere either with the high-affinity
interaction between AID and the 1a subunit (Pragnell et al.,
1994; Sheridan et al., 2003; Strube et al., 1996). If there are no
other proteins involved in the interaction with AID, our data
imply that, in the 1a subunit knock-out animal, AID is
occupied mainly by JP-45 and that such an interaction might
account, at least in part, for the severe phenotype of the mice
(Gregg et al., 1996). Strube et al. have shown that mouse
skeletal muscle cells with a null-mutation in the cchb1 gene
(encoding the 1a subunit of the Cav1) show a significant
decrease in maximum charge-movement and a shift in the
half-activation potential towards more negative potentials
(Strube et al., 1996).
To investigate the functional effect of JP-45, we altered the
stoichiometry of the JP-45–Cav1.1 supramolecular complex
either by JP-45 overexpression or by JP-45 gene silencing in
differentiated C2C12 myotubes, and then examined Cav1.1
activity by measuring charge movement.
Effect of JP-45–DsRed2 overexpression on the function
of the Cav1.1
To examine the expression of JP45 and the Cav1.1, we carried
out western blot analysis on subcellular fractions isolated from
transfected cells. Fig. 6A shows a western blot of total
microsome fractions from C2C12 cells transfected either with
pFP-N3 coupled to red fluorescent protein (DsRed2) (pFP-
N3–DsRed2) vector or with JP-45–pFP-N3–DsRed2 plasmid.
Cells transfected with the latter plasmid show an
immunoreactive band of approximately 45 kDa, which
represents endogenous JP-45, and a band of approximately 70
kDa, which represents the JP-45-DsRed fusion protein. To
verify whether overexpression of JP-45 affects the average
amount of Cav1.1 subunit, we performed immunoprecipitation
experiments. Total C2C12 lysate of control and JP45-
overexpressing cells contain two distinct high-molecular mass
bands of 175 kDa and 170 kDa that can be attributed to the
Cav1.1 subunit (Leung et al., 1987). The relative amount of
protein in the bands did not show a major change (intensity
ratio of Cav1.1 bands in JP45-overexpressing cells to those of
cells expressing empty vector was 0.971±0.06, mean ± s.d.).
C2C12 cells were transfected with JP-45–pFP-N3–DsRed2
and the expression of JP-45–DsRed2 fusion protein was
monitored by fluorescence microscopy to measure direct
charge-movement. Fig. 7A shows the maximal charge
movement. Fluorescence relationship for C2C12 cells
transfected with JP-45–pFP-N3–DsRed2 construct (A, n=17)
or pFP-N3/DsRed2 vector alone as control (B, n=15). As the
magnitude of JP-45–DsRed2 fluorescence increased, the peak
charge-movement significantly decreased (Fig. 7A), a
phenomenon that was not observed in the control cells
transfected only with the pFP-3/DsRed2 plasmid (Fig. 7B). For
analysis of the charge-movement versus membrane-voltage
relationship of cells transfected with either JP-45–pFP-
Fig. 5. JP-45 interacts with the AID domain on the I-II loop of Cav1.1. (A) GST-I-II loop fusion protein or the GST-AID containing domain
encompassed within Cav1.1 residues 336-384 were incubated with His-tagged JP-45 domain-2 fusion protein. Pull-down was performed as
described in Fig. 3; proteins in the void (V), last wash (LW) or bound to the glutathione resin (B) were separated on a 12.5% SDS-PAGE,
transferred onto nitrocellulose and probed with affinity-purified anti-JP-45 Ab. (B) Synthetic biotinylated peptides corresponding to the AID
sequence or an unrelated biotinylated peptide were used to coat neutroavidine beads, which were subsequently incubated with His-JP-45
domain 2. Proteins present in the void, last wash or bound to the beads were separated on a 12.5% SDS-PAGE, transferred onto nitrocellulose
and the immunopositive band was visualized using anti-His-tag commercial Abs. (C) A His-tagged fusion protein encompassing domain 2 JP-
45 was prepared as described in Materials and Methods. Although the fusion protein migrated slower in SDS-PAGE, its identity was verified by
direct sequencing (not shown) and by immunoblotting with anti-His Ab. Note that treatment of the fusion protein with DTT+DEPC eliminated
its immunoreactivity.
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N3–DsRed2 (Fig. 7C) or pFP-N3–DsRed2 plasmid (Fig. 7D),
data points were fitted to a Boltzmann equation of the form:
Qon = Qmax / [1 + exp(VQ1/2 – Vm)/K] ,
where Qmax is the maximum charge, Vm is the membrane
potential, VQ1/2 is the charge-movement half-activation
potential and K is the steepness of the curve. When cells were
pooled for the analysis, Qmax was significantly lower in JP-
45/pFP-N3/DsRed2 transfected than in control cells, whereas
VQ1/2 was shifted to more negative potentials in the former
group. The best fitting parameters for Qmax, VQ1/2 and K
recorded in both groups of cells are included in Table 1. No
differences in the steepness of the curve were recorded. To
better characterize the voltage-dependence of the charge
movement, the group of cells transfected with JP-45–pFP-
N3–DsRed2 (Fig. 7A,C) were separated into two subgroups,
either exhibiting the five highest or lowest Qmax values (Fig.
7E). This approach allowed to identify a more obvious
difference not only in Qmax (~threefold) but also in the half
activation potential of the charge movement (Table 1). High
expression levels of JP-45 are associated with a shift of VQ1/2
to more negative potentials of ~10 mV (Fig. 7C,D). No
differences in the steepness of the curve were observed
between these two groups of cells (Table 1).
The observation that alteration of peak charge movement is
tightly linked to the magnitude of JP-45 expression suggests
that, the stoichiometry of the JP-45/Cav1.1 supramolecular
complex is crucial for the proper function of the
Cav1.1. If this is so, we reasoned that depletion of
JP-45 in differentiated myotubes would similarly
affect the charge movement of Cav1.1. 
Effect of JP-45 gene silencing on Cav1.1
function
The mRNA encoding JP-45 was much less
abundant in C2C12 myotubes transfected with the
plasmid containing JP-45 siRNA than in cells
transfected with the control pSHAG vector (Fig.
8A). The presence of residual mRNA for JP-45
could either be due to the presence of a small
subpopulation of cells which had not been
transfected with the JP-45 siRNA construct, or to
the inability of the construct to fully eliminate the
transcript of JP-45. The amount of -actin
transcript did not differ significantly between cells
transfected with the two constructs (Fig. 8A lower
panel). Western blot analysis was performed to
confirm depletion of JP-45 in differentiated
C2C12 myotubes. Expression of JP-45 in C2C12
cells transfected with JP-45 siRNA is lower than
the detection limit of the anti-JP-45 Abs that were
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Fig. 6. Overexpression of JP-45 in C2C12 cells does not affect the
expression levels of the Cav1.1 subunit. C2C12 cells were transfected
either with the pFP-N3–DsRed2–JP-45 vector or with pFP-
N3–DsRed2 alone as control. (A) Microsomes were prepared from
transfected differentiated C2C12; 5 g protein were separated on a
10% SDS-PAGE, blotted onto nitrocellulose and probed with anti-
JP-45 polyclonal Ab, followed by HR-coupled protein G. The
immunoreactive band was visualized by chemiluminescence. Note
that control cells show the endogenous JP-45 immunoreactive band
alone, whereas cells transfected with pFP-N3–DsRed2–JP-45 show
an additional band of approximately 70 kDa, representing the
DsRed–JP-45 fusion protein. (B) Immunoprecipitation and western
blot analysis of Cav1.1 subunit expression in C2C12 cells transfected
with pFP-N3–DsRed2 or pFP-N3–DsRed2–JP-45. Results are
representative of three different transfection experiments.
Fig. 7. Effect of JP-45 overexpression on Cav1.1 charge movement. (A,B) Maximum charge-
movement versus fluorescence for C2C12 cells transfected with either pFP-N3–DsRed2 JP-45
(A) or pFP-N3/DsRed2 alone as control (B). The lines in A and B represent the linear
regression including all data points. (C,D) Charge-movement versus membrane-voltage (Vm)
for pFP-N3–DsRed2–JP-45 (C) or pFP-N3–DsRed2 plasmid (D) transfected cells fitted to a
Boltzmann equation (see text). The best fitting parameters are included in Table 1. (E) Charge-
movement versus Vm for the five highest and lowest Qmax values (E) from JP-45 transfected
cells (C).
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2151JP-45 interacts with the skeletal muscle DHP-receptor Cav1.1
raised against the N-terminal-interacting domain of the protein
(Fig. 8B). However, we did not see changes in the expression
of the housekeeping gene -actin. Having established a
reduction in transcription and expression of JP-45, we next
measured Cav1.1 charge-movement. C2C12 cells were co-
transfected with pFP-N3–DsRed2 and either the JP-45 siRNA
pSHAG vector or pSHAG vector. Based on the expression of
the DsRed2 reporter, C2C12 cells were identified and charge-
movement measurements were performed. Fig. 9A shows that
depletion of JP-45 in C2C12 myotubes is associated with a
decrease in Qmax, apparently without affecting VQ1/2 or the
steepness of the curves (Table 2). Fig. 9 also shows charge-
movement traces recorded in C2C12 cells transfected with
pSHAG (B) or JP-45 siRNA (C). The lower Qmax value in JP-
45-depleted C2C12 cells might originate from a decrease in the
amount of Cav1.1 in muscle cell membrane. To verify this, we
quantified by western blot analysis the relative amount of the
Cav1.1 in membranes of C2C12 cells that had been transfected
with JP-45 siRNA or pSHAG. The Cav1.1 shows two distinct
high-molecular mass bands of 175 kDa and 170 kDa (Fig.9
D,E) (Leung et al., 1987). Furthermore, in JP-45-depleted
C2C12 myotubes, there is a significant reduction of the
immunoreactive band that referes to the Cav1.1 (Fig. 9D,E).
Expression of the Cav1.1, measured as the ratio of the
immunopositive band between siRNA-JP-45-transfected and
control pSHAG-vector-transfected C2C12 cells, was
0.63±0.10 (mean ± s.e.m., n=4). The fractional decrease of
Cav1.1 expression is 0.37±0.09 (mean ± s.e.m., n=4) and
matches the decrease in charge movement (fractional decrease
is 0.34) shown in Table 2. These results indicate that JP-45 is
important for proper insertion of the 1.1 subunit into the
membrane of muscle cells.
A number of data have been obtained in the last few years
concerning structural determinant(s) necessary for the proper
functional insertion of Cav1.1 into the plasma membrane.
Although not all aspects of the functional insertion into the
membrane and of the targeting of the Cav1.1 are fully
understood, the emerging idea is that cooperation of the AID
domain in the I-II loop with the C-terminal domain, as well as
Table 1. Best-fitting parameters describing the voltage-
dependence of charge movement in JP-45-overexpressing
C2C12 myotubes
Best-fitting parameters
Qmax (nC F–1) VQ1/2 (mV) K
JP-45-transfected cells 6.4±0.3 –9.1±1.2 11.4±1.5
(n=17)
Control-transfected cells 8.9±0.3 (**) –5.1±0.7 (**) 10.7±1.1 (n.s.)
(vector only) (n=15)
JP-45; max Q-values 10.1±1.0 –3.2±0.03 12.5±0.6
(n=5)
JP-45; min Q-values 3.2±0.04 (**) –14.5±0.13 (**) 12.5±0.5 (n.s.)
(n=5)
Best-fitting parameters for cells transfected with JP-45 or vector only, and
of maximum (Max) and minimum (Min) charge-movement values (Q) for JP-
45. **P<0.05; n, number of cells. n.s., not significant. Values are the mean ±
s.e.m.
Fig. 8. JP-45 gene silencing in differentiated
C2C12 myotubes. (A) Total RNA was
extracted from transfected and differentiated
C2C12 cells and converted into cDNA. The
cDNA encoding JP-45 and -actin was
amplified by PCR. Amplified DNA obtained
from 50 ng or 100 ng RNA was separated on a
7.5% acrylamide gel (JP-45, top panel) or a
1% agarose gel (-actin, bottom panel).
(B) Microsomal proteins from transfected and
differentaiated C2C12 cells were prepared,
separated on a 10% SDS-PAGE, blotted onto
nitrocellulose and probed with anti-JP-45 Abs
(central panel) or commercial anti--actin
Abs, followed by peroxidase-labelled
secondary Abs. Immunoreactive bands were
visualized by chemiluminescence. Panel on
the right shows blotted proteins stained with
Ponceau Red. Results are representative of
experiments carried in three different
transfection experiments.
Table 2. Best-fitting parameters describing the voltage-
dependence of charge movement in C2C12 myotubes
transfected with JP-45 siRNA or pSHAG 
Best-fitting parameters
Qmax (nC F–1) VQ1/2 (mV) K
JP-45 siRNA (n=18) 5.8±0.37 –2.1±0.03 12.9±0.6
pSHAG vector (n=17) 8.7±0.41(*) –3.2±0.04 13.0±0.7
Values are the mean ± s.e.m.; n, number of cells; *P<0.05.
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the tertiary and quaternary structure assembly of the Cav1
complex, play a crucial role in the functional expression of the
Cav1.1 in the cell membrane (Flucher et al., 2002). However,
involvement of additional protein-protein interactions between
other polypeptides of the triad membrane
has been implied for the proper functional
insertion of the Cav1.1. We suggest that JP-
45 is one of these additional polypeptides
important for the proper assembly of the
Cav1.1 macromolecular complex into the
plasma membrane.
Here, we have shown that JP-45 domain
2 interacts with the AID sequence and with
the C-terminal domain of the Cav1.1, two
important structural determinants for
functional expression of the Cav1.1. In
addition, we have provided clear evidence
that the level of JP-45 expression in C2C12
myotubes affects the functional properties
and expression of Cav1.1. By altering
expression levels of JP-45 in differentiated
C2C12 myotubes by overexpressing its
cDNA or by JP-45 gene silencing, the
stoichiometry of the JP-45–Cav1.1
supramolecular complex is dramatically
altered. It is tempting to speculate that
alteration of the stoichiometry of the
complex influences the functional
expression of the Cav1.1 by different
mechanisms. Fig. 10 summarizes a
speculative model, which describes the
potential mode of action of JP-45 on Cav1.1
function and underlines the importance of
the correct stoichiometry of JP-45–Cav1.1 on the functional
expression of Cav1.1. Overexpression of JP-45 does not seem
to induce major changes in the expression levels of 1.1,
however it could enforce occupation of its binding site of the
I-II loop. This occupation of the JP-45 binding site within the
I-II loop might occur as consequence of a partial dissociation
of the Cav1 1a subunit or through interaction with the Cav1.1,
which does not stably bind 1a subunit (Garcia et al., 2002;
Jones et al., 2002). The I-II loop is adjacent to a repeat within
the 1.1 subunit domain involved in channel gating. It is
tempting to speculate that the effect of the overexpression and
binding of JP-45 to the binding site within I-II loop is twofold:
(1) Interference with the 1a action on gating currents (Strube
et al., 1996, Sheridan et al., 2003). (2) Perturbation of the
functional role of the adjacent repeat on channel function. Each
outcome, or the combination of both, would confer a restricted
conformation on the JP-45–Cav1.1 supramolecular complex,
Journal of Cell Science 119 (10)
Fig. 9. JP-45 gene silencing modifies Cav1.1 charge movement.
Charge-movement versus membrane-voltage (Vm) recorded in
C2C12 cells transfected with JP-45 siRNA (n=18). Control cells
were transfected with pSHAG vector (n=17). (A) Data points,
expressed as mean ± s.e.m., were fitted to a Boltzmann equation (see
text). Best fitting parameters are shown in Table 2. (B,C) Charge-
movement records in the –30 mV to +30 mV range. Numbers on the
left indicate the membrane potential. Dotted lines represent the
baseline. (D,E) Immunoprecipitation and western blot analysis of
Cav1.1 expression in C2C12 cells transfected with siRNA JP-45 and
control pSHAG vector. Two assays from a total of four. The Cav1.1
expression in D and E decreased by 69% and 28%, respectively. The
location of the molecular mass standards in kDa are depicted on the
right.
Functional insertion of alpha1.1
 into sarcotubular membranes
Wild type
1a
I II III IV
Targetting
sequence
T Tubule
membrane
JP45
RYR
Junctional SR
membrane
Inhibited conformation of the
JP45/Cav1.1 supramolecular
complex
Overexpression JP-45
I II III IV
RYR
JP45
Low density of alpha 1.1 into skeletal muscle membrane  
-
RYR
I II III IV
I II III IV
RYR
JP-45 knock-down
1a
Targetting
sequence
T Tubule
membrane
Junctional SR
membrane
Fig. 10. Model depicting the potential functional role of JP-45.
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2153JP-45 interacts with the skeletal muscle DHP-receptor Cav1.1
leading to a decrease in charge movement. However, as
indicated by western blot analysis, depletion of JP-45 affects
the total amount of Cav1.1 in the cell membrane and, in
parallel, also decreases the maximal charge movement. The
mechanism leading to the decrease in the amount of Cav1.1 in
cell membranes of JP-45-depleted cells might have several
explanations. First, our results show that JP-45 interacts with
the C-terminal domain, a region that has been shown to
encompass a sequence involved in membrane targeting. When
this sequence does not interact with JP-45, proper membrane
targeting of Cav1.1 might be impaired. Second, JP-45 is
involved in stabilizing the Cav1 complex. The functional
consequence of both events is a decrease in Qmax, with no
changes in the voltage dependence of the charge movement.
JP-45 is expressed at a very early stage of skeletal-muscle
development – its transcript appears in 15-day-old embryos
(Anderson et al., 2003) – in a developmental phase in which
ER-SR membrane transition is not completed. In immature
skeletal muscle fibres JP-45 might be localized in the ER-SR
membrane network; then, in adult muscle fibres, JP-45 is
targeted to the junctional face membrane of the SR. JP-45
might be involved in the retention of the Cav1.1 into the ER-
SR membrane during the assembly of the Cav1.1 complex at
an early stage of skeletal-muscle development. The appearance
of the 1a subunit interferes with the interaction of JP-45 with
the I-II loop of the Cav1.1. Such an event, together with an
interaction of JP-45 and the C-terminal targeting domain,
allows the functional expression of the Cav1.1 to the transverse
tubular membranes.
Materials and Methods
Experimental procedures
pGex plasmids, nitrocellulose, rainbow molecular weight markers, glutathione-
Sepharose, and [32P]dCTP were from Amersham Biosciences; goat anti-1 subunit
polyclonal Abs against the skeletal muscle Cav1.1 were from Santa Cruz
Biotechnology Inc.; isopropyl--D-thiogalactoside (IPTG), chemiluminescence kit,
restriction enzymes, fugene transfection reagent, peroxidase-conjugated anti-goat
Abs and EDTA-free anti-protease cocktail were from Roche Applied Science;
protein-G peroxidase, protein assay determination kit and SDS-PAGE protein
standards were from Bio-Rad; Talon metal affinity resin was from BD Bioscience;
tricine, anti-poly-histidine, anti--actin Abs and peroxidase-conjugated anti-mouse
Abs were from Sigma. Jet PEI transfection reagent was from Polyplus-Transfection
SAS (Illkirch, France). Protein G plus Agarose was from Santa Cruz Biotechnology,
Santa Cruz, CA. The pFP-N3/DsRed2 vector was constructed by in-frame
substitution of the sequence encoding EGFP with that of DsRed2 in the pEGFP
plasmid (Clonetech). The sequence of the plasmid backbone used for subsequent
cloning of JP-45 cDNA was confirmed by sequencing. All other chemicals were
reagents of highest grade available.
Production and purification of fusion proteins
PCR-amplified cDNA encoding overlapping sequences of mouse skeletal muscle
JP-45 were cloned in-frame into the multiple cloning site of pGex5x-3. PCR
amplification conditions and primer sequences were as previously described
(Anderson et al., 2003), using the following sets of primers (forward and reverse,
respectively): domain 1, encompassing residues 1-29 (5-AGAATTCTATGAC-
TACCAGAGGCCTGG-3 and 5-AGTCGACGGCTGGTCCCTCCAGAAAT-3);
domain 2, encompassing residues 1-80 (5-AGAATTCTATGACTACCAGAGG-
CCTGG-3 and 5-AGTCGACTGTGCTCTCCTTGCCCGCTA-3); domain 3,
encompassing residues 81-125 (5-AGAATTCTGGCAAAGCGGGAACAA-3 and
5-AGTCGACATCTCCCCAGGGCAGGTC-3); the N-terminus, encompassing
residues 1-125 (5-AGAATTCTATGACTACCAGAGGCCTGG-3 and 5-AGTCG-
ACATCTCCCCAGGGCAGGTC-3); the C-terminus, encompassing residues 149-
331 (5-AGAATTCTCGGGACGCAGTGGCT-3 and 5-AGTCGACGTCACGCC-
CCTTCCCTCGCTT-3). The EcoRI restriction site was added to facilitate
subsequent subcloning. cDNA was amplified in a Perkin Elmer GeneAmp 2400
PCR System under the following conditions: 5 minutes at 95°C, followed by 35
cycles of 40 seconds annealing at 61°C, 45 seconds extension at 72°C, 30 seconds
denaturation at 92°C and a final elongation step of 4 minutes at 72°C.
The cDNAs encoding different domains of rabbit skeletal muscle Cav1.1 1.1
subunit (Tanabe et al., 1987) were cloned into the pMR78 expression vector
designed to express His-tagged proteins. The 1.1 subunit constructs used include
the N-terminus (encompassing residues 1-51), the I-II loop (encompassing
residues 335-432), the II-III loop (encompassing residues 654-797), the III-IV
loop (encompassing residues 1059-1118), the proximal C-terminus
(encompassing residues 1382-1585), the distal C-terminus (encompassing
residues 1588-1878) and the full-length Cav1.1 1a subunit. All constructs were
checked by direct sequencing. Plasmids were used to transform E.coli DH5 cells
and fusion-protein production was induced by the addition of 100 M of
isopropyl--D-thiogalactoside (IPTG). Fusion proteins were purified, according
to the manufacturer’s recommendations, with glutathione-Sepharose for GST-
tagged fusion proteins and the Talon metal affinity resins for the His-tagged 1.1
subunit fusion proteins. The protein concentration of the purified proteins was
determined with the Bio-Rad protein assay kit and bovine serum albumin as
standard (Bradford, 1976). Proteins eluted from the affinity columns were
analysed by SDS-PAGE or Tricine-SDS-PAGE (Schagger and von Jagow, 1987)
and visualized by either Coomassie Brilliant Blue or stained with anti-poly-
histidine Abs.
Immunoprecipitation and co-immunoprecipitation experiments
Light microsomal vesicles derived from rabbit skeletal muscle were prepared as
described by Saito et al. (Saito et al., 1984) Membranes were solubilized at a final
concentration of 1 mg/ml, for 30 minutes at room temperature in a buffer composed
of 1% CHAPS, 200 mM NaCl, 1 mM dithiothreitol, 50 mM Tris-HCl pH 8.5 to
which the protease inhibitor cocktail was added. Co-immunoprecipitation
experiments of native proteins were performed as previously described with the
monoclonal anti-JP-45 Ab (Anderson et al., 2003). To identify the domain(s) of JP-
45 interacting with the Cav1.1, CHAPS-solubilized light microsomal vesicles were
incubated for 60 minutes with glutathione-Sepharose beads to which GST-JP-45
fusion proteins had been bound. Following low-speed centrifugation, the beads were
washed three times with PBS; bound proteins were eluted using glutathione elution
buffer, separated on a 10% SDS-PAGE and transferred onto nitrocellulose. To
identify JP-45-binding domains of Cav1.1, the JP-45 domain-2 fusion protein
encompassing was immobilized on GST-Sepharose beads and incubated for 60
minutes with purified His-tagged fusion proteins covering various domains of the
1.1 subunit, including the N-terminal domain, the I-II, II-III, III-IV loops, the C-
terminal-distal and C-terminal-proximal domains, and the 1a domain in 10 mM
HEPES and 150 mM NaCl plus anti-proteases. Beads were processed as described
above.
C2C12 cells were washed with PBS, treated with 1% digitonin buffer (1%
digitonin, 185 mM KCl, 1.5 mM CaCl2, 10 mM HEPES pH 7.4) on ice for 1 hour
and centrifuged at 10,000 g for 10 minutes at 4°C. The lysate (500 g total protein)
was precleared by adding 0.5 g of mouse IgG together with 20 l of Protein G
plus Agarose, and incubated for 30 minutes on a rotating device at 4°C. After
centrifugation at 1000 g, the supernatant was transferred to a fresh tube on ice.
Mouse Cav1.1 1 subunit primary Ab (IIF7) (kindly provided by Kevin P. Campbell,
University of Iowa, Howard Hughes Medical Institute, Iowa City, IA) (Leung et al.,
1987) was added and incubated overnight at 4°C. Then 20 l Protein G plus Agarose
was added to each tube and incubated for 2 hours. After centrifugation, the pellets
were washed with PBS and resuspended in 20 l of double-strength sample buffer
for 30 minutes at room temperature (Murray and Olendieck, 1997). The proteins
were separated on a 10% SDS-PAGE gel and subsequently transferred onto PVDF
membrane. Non-specific binding was blocked by incubating the membrane in 5%
non-fat milk in PBS for 60 minutes at room temperature. Incubation in the primary
Ab (1:1000 diluted in blot buffer) was for 2 hours at room temperature after which
proteins were washed three times for 5 minutes with PBS. The membrane was
incubated with anti-mouse IgG conjugated with horseradish peroxidase (HP) for 60
minutes, washed, and finally incubated in ECL Reagent and visualized in X-ray
films. Autoradiograms were scanned and analyzed with KODAK-1D Image
Analysis Software (Eastman Kodak Company, Rochester, NY).
Polyclonal Ab production and western blot analysis
Rabbit polyclonal antiserum was generated by immunizing a New Zealand white
rabbit with glutathione-Sepharose purified GST-JP-45 fusion protein encompassing
the cytoplasmic domain (aa 1-125) of JP-45. Serum was tested for the presence of
Ab one month after immunization and subsequently the IgG fraction was purified
by protein A column chromatography. Immunodetection of 1.1 subunit His-tagged
fusion proteins was carried out with monoclonal anti-poly-histidine Ab, followed
by HP-conjugated anti-mouse IgG; immunodetection of 1.1 subunit and JP-45 was
carried out as described (Anderson et al., 2003). Immunopositive bands were
visualized by chemiluminescence.
Cell culture and transfection
The mouse C2C12 muscle cell line was obtained from American Type Culture
Collection (ATCC, Rockville, MD), cultured in standard conditions and maintained
in growth medium (Dulbecco’s modified Eagle’s medium, DMEM, supplemented
with 20% foetal bovine serum, 100 units/ml penicillin and 100 g/ml streptomycin).
Cells were induced to differentiate by switching the medium to differentiation
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medium (DMEM supplemented with 2% horse serum, 100 units/ml penicillin and
100 g/ml streptomycin). For overexpression experiments, C2C12 cells were
transfected with the cDNA encoding JP-45, cloned in-frame into a hybrid pFP-
N3–DsRed2 vector. Briefly, 2 days after plating, cells were transfected by adding a
solution of plasmid DNA (1 g) and 3 l FUGENE6 previously mixed for 30
minutes at room temperature, to the tissue culture medium. Electrophysiological
measurements were made on differentiated cells 5-6 days after cell transfection. To
deplete C2C12 of JP-45, we transfected cells with a JP-45 siRNA vector pSHAG.
JP-45 RNA interference oligos were designed with siRNA Wizard software
available at InvivoGene webpage. We chose the GCTCAACAAGTGCCTGG-
TACTGGCCTCGCTG nucleotides of JP-45 coding sequence. Complementary JP-
45 RNAi oligos were synthesised according to the instructions of G. Hannon (Cold
Spring Harbor), annealed and ligated downstream U6 RNA Pol III promoter of the
pSHAG-1 vector as previously described (Treves et al., 2004). The nucleotide
sequence of the JP-45 siRNA construct was verified by sequencing. For transfection
experiments, C2C12 cells were plated on 12-mm diameter glass coverslips or on
100-mm diameter tissue culture dishes and once they reached 50-60% confluency
they were transfected by a combination of CaPO4 and Jet PEI, using a total of 7.5
g of plasmid DNA (coverslips) or 15 g plasmid DNA (cell culture dishes). The
day after transfection, the medium was changed and the cells were allowed to
recover for 24 hours. On day 3, the cells were induced to differentiate by switching
the medium to differentiation medium (DMEM supplemented with 2% horse serum,
100 units/ml penicillin and 100 g/ml streptomycin) and were transfected again as
described above to increase transfection efficiency. The next day fresh
differentiation medium was added and cells were allowed to differentiate for another
3 days, after which multinucleated myotubes were clearly visible. Total RNA was
extracted from transfected cells, converted into DNA as previously described
(Treves et al., 2004) and reverse transcriptase (RT)-PCR was carried out with JP-
45-specific or -actin-specific primers. Western bloting was done with an Ab
recognizing the N-terminal domain of JP-45.
Charge movement and fluorescence recordings
For charge movement recordings, C2C12 cells were plated on glass coverslips and
mounted in a small flow-through Lucite chamber positioned on a microscope stage.
Myotubes were continuously perfused with the external solution (see below) using
a push-pull syringe pump (WPI, Saratoga, FL.). Cells were voltage-clamped in the
whole-cell configuration of the patch-clamp (Hamill et al., 1981; Wang et al., 1999)
using an Axopatch-200B amplifier (Axon Instruments/Molecular Devices, Union
City, CA). Micropipettes were pulled from borosilicate glasses (Boralex) using a
Flaming Brown micropipette puller (P97, Sutter Instrument Co., Novato, CA) to
obtain electrode resistance ranging from 2-4 M. The composition of the internal
solution (pipette) was (in mM): 140 Cs-aspartate; 5 Mg-aspartate2, 10 Cs2EGTA
(ethylene glycol-bis(-aminoethyl ether)-N,N,NN-tetraacetic acid), 10 HEPES,
pH was adjusted to 7.4 with CsOH. The high concentration of Mg2+ in the pipette
solution helped to stabilize the preparation for longer periods. The external solution
contained (in mM): 145 TEA (tetraethylammonium)-Cl, 10 CaCl2, 10 HEPES and
0.001 tetrodotoxin. Solution pH was adjusted to 7.4 with TEA.OH. For charge
movement recording, Ca2+ current was blocked by the addition of 0.5 Cd2+ plus 0.3
La3+ to the external solution (Hamill et al., 1981; Wang et al., 1999; Wang et al.,
2000; Beam and Franzini-Armstrong, 1997).
Whole-cell currents were acquired and filtered at 5 kHz with pClamp 6.04
software (Axon). A Digidata 1200 interface (Axon) was used for A-D conversion.
Membrane current during a voltage pulse, P, was initially corrected by analogue
subtraction of linear components. The remaining linear components were digitally
subtracted on-line using hyperpolarizing control pulses of one-quarter test pulse
amplitude (–P/4 procedure) (Delbono, 1992). The four control pulses were applied
before the test pulse. We recorded the charge movement corresponding to gating of
the L-type Ca2+ channel Cav1.1. To this end, we used a prepulse protocol consisting
of a 2-second prepulse to –30 mV and a subsequent 5-millisecond repolarization to
a pedestal potential of –50 mV, followed by a 12.5-millisecond depolarization from
–50 mV to 50 mV with 10-mV intervals (Adams et al., 1990). The optimal duration
of the prepulse defined as the value at which no further immobilization of charge
movement is attained was determined to be 2 seconds, after testing a range of
prepulses from 1-6 seconds (Wang et al., 2000). Intramembrane charge movements
were calculated as the integral of the current in response to depolarizing pulses
(charge on, Qon) and were expressed per membrane capacitance (Coulombs per
Farad). The complete blockade of the inward Ca2+ current was verified by the Qon
– Qoff linear relationship. Membrane capacitance was calculated as the integral of
the transient current in response to a brief hyperpolarizing pulse from –80 mV
(holding potential) to –100 mV.
To correlate the level of transfection with charge movement, we recorded
fluorescence intensity arising from pFP-N3–DsRed2 in JP-45-transfected or pFP-
N3–DsRed2-transfected cells with a Radiance 2100K1 laser scanning confocal
system (Zeiss, Oberkochen, Germany). Fluorescence intensity was acquired in all
the areas of the cell by using a krypton laser at 568 nm and recording the emission
at 640 nm. The acquisition settings, including iris aperture (used at maximum), laser
intensity, exposure, and gain were maintained unmodified from cell to cell to
standardize recordings and make the comparison among cells valid. The maximum
fluorescent intensity of the whole cell was analyzed in digitized images and
expressed in arbitrary units (AU).
Data were analyzed using Student’s t-test or analysis of variance (ANOVA). A
value of P<0.05 was considered significant. Data are expressed as mean ± s.e.m.
with the number of observations (n).
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